AngioDynamics (ANGO) Tops Q4 EPS by 11c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
AngioDynamics (ANGO) PT Raised to $13 at Oppenheimer
July 16, 2024 3:27 PM EDTOppenheimer analyst Steven M. Lichtman raised the price target on AngioDynamics (NASDAQ: ANGO) to $13.00 (from $12.00) while maintaining a Outperform rating.
The analyst comments "ANGO's F4Q24 sales of $71.1M (+1.9% y/y pro forma) were in line with the key higher margin/growth... More
